Engineering of a bio-functionalized hybrid off-the-shelf heart valve

Biomaterials

Volumn 35, Issue 7, 2014, Pages 2130-2139

  Hinderer, Svenja ^a,b,c   Seifert, Jan ^d   Votteler, Miriam ^a   Shen, Nian ^b   Rheinlaender, Johannes ^d   Schäffer, Tilman E ^d   Schenke Layland, Katja ^a,b,e  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b FRAUNHOFER INSTITUTE FOR INTERFACIAL ENGINEERING AND BIOTECHNOLOGY IGB   (Germany)

^c UNIVERSITY OF STUTTGART   (Germany)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cardiac tissue engineering; ECM (extracellular matrix); Mechanical properties; Nanotopography; Non woven fabric

Indexed keywords

CARDIAC TISSUE ENGINEERING; ECM (EXTRACELLULAR MATRIX); EXTRACELLULAR MATRICES; HEART VALVE REPLACEMENT; LONG TERM PERFORMANCE; MECHANICAL BEHAVIOR; NANOTOPOGRAPHIES; PHYSIOLOGICAL CONDITION;

ATOMIC FORCE MICROSCOPY; ELASTIC MODULI; ENDOTHELIAL CELLS; MECHANICAL PROPERTIES; PROTEINS;

SCAFFOLDS (BIOLOGY);

COLLAGEN TYPE 1; MACROGOL DERIVATIVE; POLY(ETHYLENE GLYCOL)DIMETHACRYLATE; POLYLACTIDE; UNCLASSIFIED DRUG; VERSICAN;

ANIMAL CELL; ARTICLE; ATOMIC FORCE MICROSCOPY; BIOFUNCTIONALIZED HYBRID HEART VALVE; BIOMECHANICS; CELL ADHESION; ELECTROSPINNING; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HEART DEVELOPMENT; HEART VALVE; HEART VALVE DEVELOPMENT; HEART VALVE LEAFLET; HEART VALVE PROSTHESIS; HUMAN; HUMAN TISSUE; LEYDIG CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RIGIDITY; TENSILE STRENGTH; TISSUE ENGINEERING; TISSUE STRUCTURE; VALVULAR ENDOTHELIAL CELL; VALVULAR INTERSTITIAL CELL; WETTABILITY; YOUNG MODULUS;

CARDIAC TISSUE ENGINEERING; ECM (EXTRACELLULAR MATRIX); MECHANICAL PROPERTIES; NANOTOPOGRAPHY; NON-WOVEN FABRIC;

ANIMALS; HEART VALVE PROSTHESIS; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, ELECTRON, SCANNING; SWINE; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84891373491     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.10.080     Document Type: Article

References (54)

1. Sewell-Loftin M.K., Chun Y., Khademhosseini A., Merryman W.D. EMT-inducing biomaterials for heart valve engineering: taking cues from developmental biology. JCardiovasc Transl Res 2011, 4:658-671.
2. Frantz C., Stewart K.M., Weaver V.M. The extracellular matrix at a glance. JCell Sci 2010, 123:4195-4200.
3. Agarwal S., Wendorff J.H., Greiner A. Progress in the field of electrospinning for tissue engineering applications. Adv Mater 2009, 21:3343-3351.
4. Schenke-Layland K., Xie J., Angelis E., Starcher B., Wu K., Riemann I., et al. Increased degradation of extracellular matrix structures of lacrimal glands implicated in the pathogenesis of Sjogren's syndrome. Matrix Biol 2008, 27:53-66.
5. Hinderer S., Schesny M., Bayrak A., Ibold B., Hampel M., Walles T., et al. Engineering of fibrillar decorin matrices for a tissue-engineered trachea. Biomaterials 2012, 33:5259-5266.
6. Li M., Mondrinos M.J., Gandhi M.R., Ko F.K., Weiss A.S., Lelkes P.I. Electrospun protein fibers as matrices for tissue engineering. Biomaterials 2005, 26:5999-6008.
7. Hopkins A.M., De Laporte L., Tortelli F., Spedden E., Staii C., Atherton T.J., et al. Silk hydrogels as soft substrates for neural tissue engineering. Adv Funct Mater 2013, 10.1002/adfm.201300435.
8. Kim T.G., Shin H., Lim D.W. Biomimetic scaffolds for tissue engineering. Adv Funct Mater 2012, 22:2446-2468.
9. Hanjaya-Putra D., Wong K.T., Hirotsu K., Khetan S., Burdick J.A., Gerecht S. Spatial control of cell-mediated degradation to regulate vasculogenesis and angiogenesis in hyaluronan hydrogels. Biomaterials 2012, 33:6123-6131.
10. Schenke-Layland K., Nsair A., Van Handel B., Angelis E., Gluck J.M., Votteler M., et al. Recapitulation of the embryonic cardiovascular progenitor cell niche. Biomaterials 2011, 32:2748-2756.
11. Jacot J.G., McCulloch A.D., Omens J.H. Substrate stiffness affects the functional maturation of neonatal rat ventricular myocytes. Biophys J 2008, 95:3479-3487.
12. Bronshtein T., Au-Yeung G.C.T., Sarig U., Nguyen E.B.-V., Mhaisalkar P.S., Boey F.Y.C., et al. Amathematical model for analyzing the elasticity, viscosity, and failure of soft tissue: comparison of native and decellularized porcine cardiac extracellular matrix for tissue engineering. Tissue Eng Part C Methods 2012, 19:620-630.
13. Arjunon S., Rathan S., Jo H., Yoganathan A. Aortic valve: mechanical environment and mechanobiology. Ann Biomed Eng 2013, 41:1331-1346.
14. Schleicher M., Sammler G., Schmauder M., Fritze O., Huber A., Schenke-Layland K., et al. Simplified pulse reactor for real-time long-term invitro testing of biological heart valves. Ann Biomed Eng 2010, 38:1919-1927.
15. Schenke-Layland K., Riemann I., Opitz F., Konig K., Halbhuber K.J., Stock U.A. Comparative study of cellular and extracellular matrix composition of native and tissue engineered heart valves. Matrix Biol 2004, 23:113-125.
16. Radmacher M., Fritz M., Kacher C.M., Cleveland J.P., Hansma P.K. Measuring the viscoelastic properties of human platelets with the atomic force microscope. Biophys J 1996, 70:556-567.
17. Braunsmann C., Hammer C.M., Rheinlaender J., Kruse F.E., Schäffer T.E., Schlötzer-Schrehardt U. Evaluation of lamina cribrosa and peripapillary sclera stiffness in pseudoexfoliation and normal eyes by atomic force microscopy. Invest Ophthamol Vis Sci 2012, 53:2960-2967.
18. Cook S.M., Schäffer T.E., Chynoweth K.M., Wigton M., Simmonds R.W., Lang K.M. Practical implementation of dynamic methods for measuring atomic force microscope cantilever spring constants. Nanotechnology 2006, 17:2135.
19. Hertz H. Ueber die Berührung fester elastischer Körper. JReine Angew Math 1882, 156.
20. Cross S.E., Jin Y.-S., Rao J., Gimzewski J.K. Nanomechanical analysis of cells from cancer patients. Nat Nanotechnol 2007, 2:780-783.
21. Hayenga H.N., Trache A., Trzeciakowski J., Humphrey J.D. Regional atherosclerotic plaque properties in ApoE-/- mice quantified by atomic force, immunofluorescence, and light microscopy. JVasc Res 2011, 48:495-504.
22. Shimizu Y., Kihara T., Haghparast S.M.A., Yuba S., Miyake J. Simple display system of mechanical properties of cells and their dispersion. PLoS One 2012, 7:e34305.
23. Votteler M., Berrio D.A.C., Horke A., Sabatier L., Reinhardt D.P., Nsair A., et al. Elastogenesis at the onset of human cardiac valve development. Development 2013, 140:2345-2353.
24. Pudlas M., Koch S., Bolwien C., Thude S., Jenne N., Hirth T., et al. Raman spectroscopy: a noninvasive analysis tool for the discrimination of human skin cells. Tissue Eng Part C Methods 2011, 17:1027-1040.
25. Sheth M., Kumar R.A., Davé V., Gross R.A., McCarthy S.P. Biodegradable polymer blends of poly(lactic acid) and poly(ethylene glycol). JAppl Polym Sci 1997, 66:1495-1505.
26. Buchatip S., Petchsuk A., Kongsuwan K. Synthesis and mechanical properties of poly (LLA-co-DLLA) copolymers. JMagn Magn Mater 2008, 18:175-180.
27. Jacobsen S., Fritz H.G. Plasticizing polylactide-the effect of different plasticizers on the mechanical properties. Polym Eng Sci 1999, 39:1303-1310.
28. Wang B.-Y., Fu S.-Z., Ni P.-Y., Peng J.-R., Zheng L., Luo F., et al. Electrospun polylactide/poly(ethylene glycol) hybrid fibrous scaffolds for tissue engineering. JBiomed Mater Res A 2012, 100A:441-449.
29. Bridges A.W., Garcia A.J. Anti-inflammatory polymeric coatings for implantable biomaterials and devices. JDiabetes Sci Technol 2008, 2:984-994.
30. Kim P., Kim D.H., Kim B., Choi S.K., Lee S.H., Khademhosseini A., et al. Fabrication of nanostructures of polyethylene glycol for applications to protein adsorption and cell adhesion. Nanotechnology 2005, 16:2420.
31. Roberts M.J., Bentley M.D., Harris J.M. Chemistry for peptide and protein PEGylation. Adv Drug Deliv Rev 2002, 54:459-476.
32. Baiardo M., Frisoni G., Scandola M., Rimelen M., Lips D., Ruffieux K., et al. Thermal and mechanical properties of plasticized poly(L-lactic acid). JAppl Polym Sci 2003, 90:1731-1738.
33. Masoumi N., Johnson K.L., Howell M.C., Engelmayr G.C. Valvular interstitial cell seeded poly(glycerol sebacate) scaffolds: toward a biomimetic invitro model for heart valve tissue engineering. Acta Biomater 2013, 9:5974-5988.
34. Stradins P., Lacis R., Ozolanta I., Purina B., Ose V., Feldmane L., et al. Comparison of biomechanical and structural properties between human aortic and pulmonary valve. Eur J Cardiothorac Surg 2004, 26:634-639.
35. Chen Q., Bruyneel A., Carr C., Czernuszka J. Bio-mechanical properties of novel bi-layer collagen-elastin scaffolds for heart valve tissue engineering. Procedia Eng 2013, 59:247-254.
36. Taylor P.M., Cass A.E.G., Yacoub M.H. Extracellular matrix scaffolds for tissue engineering heart valves. Prog Pediatr Cardiol 2006, 21:219-225.
37. Zhao R., Sider K.L., Simmons C.A. Measurement of layer-specific mechanical properties in multilayered biomaterials by micropipette aspiration. Acta Biomater 2011, 7:1220-1227.
38. He L., Liao S., Quan D., Ma K., Chan C., Ramakrishna S., et al. Synergistic effects of electrospun PLLA fiber dimension and pattern on neonatal mouse cerebellum C17.2 stem cells. Acta Biomater 2010, 6:2960-2969.
39. Mo X.M., Xu C.Y., Kotaki M., Ramakrishna S. Electrospun P(LLA-CL) nanofiber: a biomimetic extracellular matrix for smooth muscle cell and endothelial cell proliferation. Biomaterials 2004, 25:1883-1890.
40. Chester A.H., Taylor P.M. Molecular and functional characteristics of heart-valve interstitial cells. Philos Trans R Soc B Biol Sci 2007, 362:1437-1443.
41. Luo M., Guan J.-L. Focal adhesion kinase: a prominent determinant in breast cancer initiation, progression and metastasis. Cancer Lett 2010, 289:127-139.
42. Mecham R.P. Overview of extracellular matrix. Curr Protoc Cell Biol 2001, 10.1.1-10.1.14.
43. Schaefer L., Schaefer R.M. Proteoglycans: from structural compounds to signaling molecules. Cell Tissue Res 2010, 339:237-246.
44. Aikawa E., Whittaker P., Farber M., Mendelson K., Padera R.F., Aikawa M., et al. Human semilunar cardiac valve remodeling by activated cells from fetus to adult: implications for postnatal adaptation, pathology, and tissue engineering. Circulation 2006, 113:1344-1352.
45. Peacock J.D., Lu Y., Koch M., Kadler K.E., Lincoln J. Temporal and spatial expression of collagens during murine atrioventricular heart valve development and maintenance. Dev Dyn 2008, 237:3051-3058.
46. Lindsey S.E., Butcher J.T. The cycle of form and function in cardiac valvulogenesis. Global Cardiol Sci Pract 2011, 2011(2):10.
47. Schroeder J., Jackson L., Lee D., Camenisch T. Form and function of developing heart valves: coordination by extracellular matrix and growth factor signaling. JMol Med 2003, 81:392-403.
48. Kruithof B.P.T., Krawitz S.A., Gaussin V. Atrioventricular valve development during late embryonic and postnatal stages involves condensation and extracellular matrix remodeling. Dev Biol 2007, 302:208-217.
49. Henderson D.J., Copp A.J. Versican expression is associated with chamber specification, septation, and valvulogenesis in the developing mouse heart. Circ Res 1998, 83:523-532.
50. Hinton R.B., Lincoln J., Deutsch G.H., Osinska H., Manning P.B., Benson D.W., et al. Extracellular matrix remodeling and organization in developing and diseased aortic valves. Circ Res 2006, 98:1431-1438.
51. Hatano S., Kimata K., Hiraiwa N., Kusakabe M., Isogai Z., Adachi E., et al. Versican/PG-M is essential for ventricular septal formation subsequent to cardiac atrioventricular cushion development. Glycobiology 2012, 22:1268-1277.
52. Lincoln J., Alfieri C.M., Yutzey K.E. Development of heart valve leaflets and supporting apparatus in chicken and mouse embryos. Dev Dyn 2004, 230:239-250.
53. Wight T.N. Versican: a versatile extracellular matrix proteoglycan in cell biology. Curr Opin Cell Biol 2002, 14:617-623.
54. Perissinotto D., Iacopetti P., Bellina I., Doliana R., Colombatti A., Pettway Z., et al. Avian neural crest cell migration is diversely regulated by the two major hyaluronan-binding proteoglycans PG-M/versican and aggrecan. Development 2000, 127:2823-2842.